Here our findings reveal a metabolic mechanism for CREB1-mediated tumor cell survival, and also suggest that targeting GCLM or oxidative stress potentially could be a therapeutic approach for treatment of tumors with relatively high expression of CREB1 family proteins. Here, CREB1 is linked to neoplasm.